Objectives: To assess the effectiveness of using exosomes and botulinum toxin type A for treating large facial pores, facial flushing, and skin pigmentation.
Introduction: Exosomes have recently received much attention for their effects on facial rejuvenation. The addition of exosomes to the intradermal injection of botulinum toxin was explored as a treatment protocol for skin conditions such as large skin pores, skin flushing, and skin pigmentation.
Materials / method: Subjects with large facial pores, medium to severe skin flushing and skin pigmentation were separately selected for this study. These subjects were treated using the following sequence. On day 1, the subjects were treated via air dissection and micro-droplet Botulinum Toxin type A. After one week, exosome was applied to the treatment area using a meso-roller. Two weeks later, another round of air dissection and micro-droplet BTXA injection was followed by the exosome application the following week. The subjects were followed up 3 weeks and 6 weeks after the first treatment.
Results: Visible improvements to pore size and depth, skin flushing, and skin pigmentation were first documented at 3 weeks after initial treatment. At 6 weeks after initial treatment, assessment using QuantifiCare 3D Lifeviz and Mark Vu facial skin analyzer showed a significant decrease in skin pores, improvement in skin flushing, and improvement in skin pigmentation.
Conclusion: In this study, the use of exosomes and Botulinum Toxin type A has been demonstrated to be an effective protocol for the treatment of large facial pores, facial flushing, and skin pigmentation.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。